PaVe-GT > Publications > Successfully Navigating FDA Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The NIH PaVe-GT Experience
Richa M. Lomash, Oleg Shchelochkov, Randy J. Chandler, Charles P. Venditti, Anne Pariser, and Elizabeth Ottinger